University of Texas Researchers Break Bacterial Defenses to Restore Antibiotic Efficacy in Cystic Fibrosis Cases

UT Austin scientists discover a way to stop resistant bacteria from shielding neighbors, restoring the power of antibiotics against stubborn infections.

By: AXL Media

Published: Apr 21, 2026, 9:42 AM EDT

Source: Information for this report was sourced from EurekAlert!

Disrupting the Collective Shield of Pathogenic Communities

In the complex environment of a clinical infection, bacteria rarely act in isolation, often forming communities where resistant strains provide a "cross-protection" umbrella for more vulnerable species. New research published in the journal eLife reveals a strategy to strip away this collective immunity by targeting the internal machinery bacteria use to build their defenses. Lead author Nikol Kadeřábková of the University of Texas at Austin explained that by disabling a specific protein-folding system, the research team was able to render multidrug-resistant pathogens vulnerable once more. This discovery addresses a critical flaw in traditional treatments that often fail because one resistant microbe degrades antibiotics for the entire colony.

Mimicking the Reality of Cystic Fibrosis Lung Infections

To test their findings under realistic conditions, the team moved beyond single-pathogen studies to create synthetic communities of Pseudomonas aeruginosa and Stenotrophomonas maltophilia. These two species are frequently found together in the lungs of patients with cystic fibrosis, where they create a formidable barrier to recovery. While Pseudomonas is often the primary target of medical intervention, Stenotrophomonas is notoriously resistant to nearly all available antibiotics, including the common β-lactam class. The study demonstrated that the presence of the latter significantly hinders the effectiveness of penicillins and cephalosporins by releasing enzymes into the surrounding environment that neutralize the drugs before they can reach their targets.

Targeting the Protein-Folding Machinery of Resistance

The core of the breakthrough lies in the inhibition of the systems responsible for assembling the enzymes that give bacteria their edge. Resistant microbes rely on a protein-folding system to construct β-lactamases, the enzymes that physically break down antibiotic molecules. The researchers utilized both genetic deletion and chemical inhibitors to prove that disrupting this assembly line effectively "disarms" the bacteria. Without the ability to properly fold these defense proteins, the pathogens lose their individual resistance and their ability to protect their neighbors. This dual impact ensures that the antibiotic treatment can penetrate the entire bacterial community rather than being n...